Tag: Pulmonary Arterial Hypertension

Early treatment with ambrisentan might prevent PAH development in patients with SSc

Presented By
Dr Panagiota Xanthouli, Heidelberg University Hospital, Germany
Trial
Phase 2, EDITA
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:34

Exercise and diet improve functional status in PAH

Presented By
Dr Gustavo Heresi, Cleveland Clinic, OH, USA
Trial
PHINE
Conference
ATS 2024
Type
News article

11 June 2024 10:58

TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH

Presented By
Prof. Robert Frantz, Mayo Clinic, MN, USA
Trial
Phase 2, TORREY
Conference
ATS 2023
Type
News article

12 June 2023 16:16

Sotatercept improves exercise capacity in patients with PAH

Presented By
Prof. Marius Hoeper, Hannover Medical School, Germany
Trial
Phase 3, STELLAR
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 17:10

Fixed-dose macitentan plus tadalafil superior to either agent alone in PAH

Presented By
Prof. Kelly Chin, UT Southwestern Medical Center, TX, USA
Trial
Phase 3, A DUE
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 17:08

Sotatercept: potential new treatment option for PAH

Presented By
Prof. Vallerie McLaughlin, University of Michigan, USA
Trial
Phase 2, PULSAR
Conference
AHA 2020
Type
Peer-reviewed article

18 February 2021 11:37

Pulmonary arterial hypertension: early treatment with selexipag most effective

Presented By
Prof. Sean Gaine, Mater Misericordiae University Hospital, Ireland
Trial
GRIPHON
Conference
ATS 2019
Type
Peer-reviewed article

23 July 2019 22:32

Tuberous sclerosis complex 2 may be a novel target in pulmonary arterial hypertension therapy

Presented By
Dr Yuanjun Shen, University of Pittsburgh Medical Center, USA
Conference
ATS 2019
Type
Peer-reviewed article

23 July 2019 14:55

Treatment patterns PAH have changed recently

Conference
ACC 2019
Type
Peer-reviewed article

6 June 2019 11:19

Risk stratification

Presented By
Prof. Olivier Sitbon, Hôpitaux Universitaires Paris-Sud, France
Conference
ERS 2018
Type
Peer-reviewed article

7 November 2018 23:55

New therapeutic targets: moving form pre-clinical data to phase 2 studies

Presented By
Prof. Martin Wilkins, Imperial College London, United Kingdom
Conference
ERS 2018
Type
Peer-reviewed article

7 November 2017 22:05
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com